Axinn Attorneys Named to Best Lawyers 2023
August 18, 2022
Axinn is pleased to announce that eight attorneys have been named to the 2023 list of “Best Lawyers in America” and five attorneys have been named to the list of “Ones to Watch.” Two attorneys have been named “Lawyer of the Year” in their individual practice areas. Each year, Best Lawyers®partners with U.S. News & World Report, the leading rankings publication in the United States to rank law firms and attorneys across the country. Best Lawyers®compiles their lists of outstanding attorneys by conducting peer-review surveys in which tens of thousands of leading lawyers confidentially evaluate their professional peers.
Antitrust Law
Stephen Axinn
Lisl Dunlop
John Harkrider
Michael Keeley
Litigation – Antitrust
Mark Alexander
Stephen Axinn
Lisl Dunlop
John Harkrider (Lawyer of the Year)
Michael Keeley
Litigation – Commercial
Francis Morrison III
Litigation – Intellectual Property
Matthew Becker
Francis Morrison III
Litigation – Insurance
Thomas Rohback
Litigation – Patent
Matthew Becker (Lawyer of the Year)
Francis Morrison III
Trade Secrets Law
Francis Morrison III
“Ones to Watch”
Rebecca Clegg: Intellectual Property Law, Litigation – Intellectual Property, Litigation – Patent
James Hunsberger: Antitrust Law
Kenina Lee: Antitrust Law, Litigation – Antitrust
Carol Xianxiao Liu: Antitrust Law
Lindsey Strang: Antitrust Law
To subscribe to our publications, click here.
Featured Insights
Featured Insights
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Sponsorship
Antitrust
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
The 32nd Annual Marketing Partner Forum
Event
SABA North America Corporate Counsel Retreat 2025
Sponsorship
Antitrust
Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2025
Client Alerts
Antitrust
Four Axinn Thought Leadership Pieces Nominated for the Antitrust Writing Awards
Awards & Recognitions
Antitrust
Merger Remedies Back in Vogue Under Trump
Media Mentions
Antitrust
Three Takeaways from the Initial Determination at the ITC Regarding Standard Essential Patents in the 1380 Investigation
Axinn Viewpoints
Intellectual Property
A POSA’s Motivation Is Not Required To Be the Same as the Inventor’s in Evaluating Obviousness
Axinn Viewpoints
Intellectual Property